{"id":1835,"date":"2023-03-10T00:47:02","date_gmt":"2023-03-10T00:47:02","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1835"},"modified":"2026-02-23T00:17:53","modified_gmt":"2026-02-23T00:17:53","slug":"msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/","title":{"rendered":"MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1 (Contributed by Dr Niki Flaum)"},"content":{"rendered":"

The genetic cause in women diagnosed with ovarian cancer (OC) under thirty years of age is unclear. It is known that the histology and genetics of these cancers are different to those in the general OC patient population. On reviewing the genes affected in women diagnosed under thirty years in the North-West of England we found genes involved in DNA mismatch repair, especially MSH2, to be affected. Genes important in overall OC risk such as BRCA1 and BRCA2 do not seem significant in this population. The risk of OC in women with an MSH2 mutation is >2% by age 35. (https:\/\/jmg.bmj.com\/content\/early\/2023\/03\/08\/jmg-2022-109055<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

The genetic cause in women diagnosed with ovarian cancer (OC) under thirty years of age is unclear. It is known that the histology and genetics of these cancers are different to those in the general OC patient population. On reviewing the genes affected in women diagnosed under thirty years in the North-West of England we […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1835","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nMSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1 (Contributed by Dr Niki Flaum) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1 (Contributed by Dr Niki Flaum) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"The genetic cause in women diagnosed with ovarian cancer (OC) under thirty years of age is unclear. It is known that the histology and genetics of these cancers are different to those in the general OC patient population. On reviewing the genes affected in women diagnosed under thirty years in the North-West of England we [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-10T00:47:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T00:17:53+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/03\\\/10\\\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/03\\\/10\\\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1 (Contributed by Dr Niki Flaum)\",\"datePublished\":\"2023-03-10T00:47:02+00:00\",\"dateModified\":\"2026-02-23T00:17:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/03\\\/10\\\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\\\/\"},\"wordCount\":124,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/03\\\/10\\\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/03\\\/10\\\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/03\\\/10\\\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\\\/\",\"name\":\"MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1 (Contributed by Dr Niki Flaum) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2023-03-10T00:47:02+00:00\",\"dateModified\":\"2026-02-23T00:17:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/03\\\/10\\\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/03\\\/10\\\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/03\\\/10\\\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1 (Contributed by Dr Niki Flaum)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1 (Contributed by Dr Niki Flaum) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/","og_locale":"en_US","og_type":"article","og_title":"MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1 (Contributed by Dr Niki Flaum) - JMG Contact blog","og_description":"The genetic cause in women diagnosed with ovarian cancer (OC) under thirty years of age is unclear. It is known that the histology and genetics of these cancers are different to those in the general OC patient population. On reviewing the genes affected in women diagnosed under thirty years in the North-West of England we [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/","og_site_name":"JMG Contact blog","article_published_time":"2023-03-10T00:47:02+00:00","article_modified_time":"2026-02-23T00:17:53+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1 (Contributed by Dr Niki Flaum)","datePublished":"2023-03-10T00:47:02+00:00","dateModified":"2026-02-23T00:17:53+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/"},"wordCount":124,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/","url":"https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/","name":"MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1 (Contributed by Dr Niki Flaum) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2023-03-10T00:47:02+00:00","dateModified":"2026-02-23T00:17:53+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/03\/10\/msh2-is-the-very-young-onset-ovarian-cancer-predisposition-gene-not-brca1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1 (Contributed by Dr Niki Flaum)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1835"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1835\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}